JP Morgan Maintains Neutral on Amrize, Lowers Price Target to $48

Benzinga · 5d ago
JP Morgan analyst Adrian Huerta maintains Amrize (NYSE:AMRZ) with a Neutral and lowers the price target from $52 to $48.